Equity
€98,157 ▼ 41.1%
HS Pneumo-Allergo paid out €146,100 in dividends. That is 177% of the 2025 profit.
HS Pneumo-Allergo
Lifetime
4 annual accounts with figures on one time axispeak €124,606 (2023)
€108,656▲ 110%
peak €98,527 (2023)
€82,540▲ 91.4%
peak €166,717 (2024)
€98,157▼ 41.1%
€30,878▲ 43.2%
Board1 name since 2022
1 directorSIMONIS Hélène
Documentsfilings and deeds
17-08-202617 days late
2025micro format
Gross margin from €51,863 to €108,656Result from €43,121 to €82,540Dividend €146,100Equity from €166,717 to €98,157Debts from €21,568 to €30,878Cash from €25,109 to €12,094
Key points
from the 2025 annual accountsChecked score
94
Excellent
Financially stronger than 51% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,180 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%lowest value
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025lowest value
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: 0.1%▲ +0.1 percentage points vs 07-2025
09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: 0.1%▲ +0.1 percentage points vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: 0.1%▲ +0.1 percentage points vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026highest value
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Founded in 2022
lowers risk
Sector: Human health activities (NACE 86)
Figures for financial year 2025 (filed on 18-08-2026)
Equity €98,157 (76.1% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 27% on liquidity, 80% on profitability and 14% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as HS Pneumo-Allergo has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
The bankruptcy probability of HS Pneumo-Allergo itself is lower: 0.1% within 12 months. It rests on far more data about HS Pneumo-Allergo than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for HS Pneumo-Allergo. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.91 (8.5 in 2024), above the usual 1.5. Short-term debt is 23.6% and cash 9.4% of total assets. 23.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 17 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-08-2026, 17 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filingsDeviation from the deadline
2025
17 days late
2024
30 days late
2023
21 days late
2022
28 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 24 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 August (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0790579890
Incorporation
Founding capital of €1,500, 100 shares · Founder: SIMONIS Hélène · Appointment: SIMONIS Hélène (director) · published on 12-09-2022 · Gazette deed
First establishment
Voie de Liège 125, Soumagne
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| HS Pneumo-Allergo Soumagne | €129,035 | €108,656 | 76.1% | - |
| Dr. Marie-Astrid Denys Ghent | €143,402 | €107,036 | 74.0% | - |
| DR. GERT-JAN OPSOMER, ORTHOPEDIST Maasmechelen | €148,585 | €112,945 | 0.9% | - |
| MPR Dr Den Brave Chaudfontaine | €155,181 | €98,427 | 48.3% | - |
| PHTN-Médical Modave | €110,820 | €119,460 | 46.8% | - |
| Docteur BEAUDRY OPHTALMOLOGIE Huy | €141,392 | €113,330 | 34.6% | - |
| M-PIBOX Trooz | €129,916 | €106,469 | 14.9% | - |
These companies have the same main activity as HS Pneumo-Allergo: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €111,000 and €155,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 08-09-2022Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.336.812.8454630 Soumagne, since 08-09-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 19-06-2026
Insights on HS Pneumo-Allergo
HS Pneumo-Allergo files the micro format. That format states no turnover. The gross margin rose from €65,778 in 2022 to €108,656 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about HS Pneumo-Allergo
- What is the company number of HS Pneumo-Allergo?
- The company number of HS Pneumo-Allergo is 0790.579.890. The VAT number is the same number with BE in front: BE 0790.579.890.
- Where is HS Pneumo-Allergo based?
- The registered office is at Voie de Liège 125, 4630 Soumagne.Company details
- What does HS Pneumo-Allergo do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of HS Pneumo-Allergo?
- HS Pneumo-Allergo is a private limited company (BV).
- When was HS Pneumo-Allergo founded?
- HS Pneumo-Allergo was founded on 08-09-2022.
- Is HS Pneumo-Allergo still active?
- Yes, HS Pneumo-Allergo is an active enterprise in the KBO register.
- What is the turnover of HS Pneumo-Allergo?
- The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €108,656 and 41 comparable companies (NACE 86220). It probably lies between €170,000 and €270,000.Financials
- Is HS Pneumo-Allergo profitable?
- In financial year 2025, HS Pneumo-Allergo made a profit of €82,540.
- Where can I find the annual accounts of HS Pneumo-Allergo?
- HS Pneumo-Allergo filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of HS Pneumo-Allergo due?
- HS Pneumo-Allergo must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.